Shed Secures Exclusive U.S. Telehealth Access to ROXUS®, a Rapid-Acting Intranasal Treatment for Erectile Dysfunction through LTR Pharma

Exclusive agreement positions Shed as the only U.S. direct-to-consumer telehealth platform offering ROXUS®. ROXUS® will be available exclusively through Mavrox, Shed's consumer-facing men's health platform.